Jump to Navigation
ChemRegen™
  • Share Us
  • ShareMore Bookmark & Share
  • ChemRegen RSS Feed
  • Home
  • About Us
    • Management Team
    • Board of Directors
    • Scientific Team
  • Research & Technology
    • Cardiac Regeneration
    • Breast Cancer
    • Colorectal Cancer
  • News & Media
  • Partnering / Investors
  • Contact Us

You are here

Home ›

Legal Information

Coming Soon

Main menu

  • Home
  • About Us
  • Research & Technology
  • News & Media
  • Partnering / Investors
  • Contact Us

In the News

“Pancreatic cancer drug-sensitivity predicted by synergy of PAWI-2 and protein biomarker expression”

Submitted by ChemRegen on Fri, 09/18/2020 - 10:24

Potent inhibitor of pancreatic cancer stem cells that synergizes current standard of care, PAWI-2 is featured in Investigational New Drugs.

  • Read more about “Pancreatic cancer drug-sensitivity predicted by synergy of PAWI-2 and protein biomarker expression”
  • ChemRegen's blog
  • Log in to post comments

Collaborators

The Human BioMolecular Research Institute

The Sanford-Burnham Medical Research Institute

Signup

Stay Informed. Join our mailing list to receive the latest news...

Footer Nav Right

  • Home
  • About Us
  • Research & Technology
  • News & Media
  • Partnering & Investors
  • Contact Us

Footer Nav Left

  • © 2012 ChemRegen
  • Legal Information